Fig. 5
From: SAMD13 serves as a useful prognostic biomarker for hepatocellular carcinoma
Expression profiles and clinical status of SAMD13 in HCC. A Putative copy number alterations and B differences in American Joint Committee on Cancer Code staging. Box plot of methylation levels with copy number amplification C and tumor stage D for SAMD13 in HCC (M value, p value < 0.05). − 1: single copy deletion; 0: diploid normal copy; + 1: low-level copy number amplification; + 2: high-level copy number amplification